Evidence map›Paper›PMID 42795909›Full record

ArticleJournal of clinical medicine2026

Clinicopathological Characteristics and Survival Outcomes of Male Breast Lymphoma.

Abdulmunir Azizy, Izzet Dogan, Mustafa Bozkurt, Onur Dulgeroglu, Serap Yucel, Ibrahim Yildiz, Irmak Durur Subasi, Ali Arican, Cihan Uras

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Abdulmunir AzizyMedical Oncology, Istanbul University Institute of Oncology, Istanbul 34093, Turkey.ORCID 0000-0002-5068-6472
Izzet DoganMedical Oncology, Acibadem Healthcare Group, Istanbul 34457, Turkey.ORCID 0000-0003-1018-1119
Mustafa BozkurtMedical Oncology, Acibadem Healthcare Group, Istanbul 34457, Turkey.
Onur DulgerogluGeneral Surgery, Acibadem Healthcare Group, Istanbul 34457, Turkey.ORCID 0000-0002-6427-9077
Serap YucelRadiation Oncology, Acibadem Healthcare Group, Istanbul 34457, Turkey.ORCID 0000-0003-4948-8927
Ibrahim YildizMedical Oncology, Acibadem Healthcare Group, Istanbul 34457, Turkey.
Irmak Durur SubasiRadiology, Acibadem Healthcare Group, Istanbul 34457, Turkey.ORCID 0000-0003-3122-4499
Ali AricanMedical Oncology, Acibadem Healthcare Group, Istanbul 34457, Turkey.
Cihan UrasGeneral Surgery, Acibadem Healthcare Group, Istanbul 34457, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

male breast lymphomaprimary breast lymphomaSEERsurvival

Identifiers

PMID42795909
PMCPMC13607678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.